Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01849978 · ClinicalTrials.gov registry record · NA
Enhancing Exercise in Breast Cancer Survivors
A NA study of Breast Cancer, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT01849978: Completed NA study of Breast Cancer, sponsored by Duke University.
NCT01849978 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 81 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01849978, a NA study of Breast Cancer, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether or not providing early stage breast cancer survivors with tips on making exercise more enjoyable promotes greater levels of moderate to strenuous exercise.
Primary Outcome
participants will self-report minutes of physical activity at baseline, 1 month, and 3 months after receiving intervention materials.
Conditions Studied
Interventions
- BEHAVIORAL Newsletter about physical activity and breast cancer survivors
- BEHAVIORAL Changing your habits brochure
- BEHAVIORAL Tips for making exercise enjoyable and personally-valued
- BEHAVIORAL Testimonials from breast cancer survivors
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01849978 record still lists
NCT01849978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Newsletter about physical activity and breast cancer survivors is the first listed.
NCT01849978 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01849978 about?
NCT01849978 is a clinical study titled "Enhancing Exercise in Breast Cancer Survivors". This study will examine whether or not providing early stage breast cancer survivors with tips on making exercise more enjoyable promotes greater levels of moderate to strenuous exercise.
What is the current status of trial NCT01849978?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2014-05. Estimated completion is 2015-04.
What conditions does trial NCT01849978 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01849978?
The interventions under investigation include: Newsletter about physical activity and breast cancer survivors (BEHAVIORAL), Changing your habits brochure (BEHAVIORAL), Tips for making exercise enjoyable and personally-valued (BEHAVIORAL), Testimonials from breast cancer survivors (BEHAVIORAL).
Who is sponsoring clinical trial NCT01849978?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01849978 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01849978's enrollment target sits among peer trials
81 644th of 1224 higher than 577 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia